GOT1 and familial pancreatic carcinoma: The above results indicate that CCR2 is a potential binding protein of GOT1 and that CCR2 is upregulated in pancreatic cancer tissues and cell lines, suggesting that CCR2 may be involved in pancreatic cancer progression.